Global News
- All
- AI
- Markets
- Macroeconomics
Despite Merck & Co.’s strong performance relative to its peers over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects
IBM’s volume was three times its 30-day average yesterday. It also had a high standard deviation of -3.46. Big moves are the norm for IBM; this latest decline suggests the good times could be over.
While PepsiCo has underperformed the Nasdaq Composite over the past year, analysts remain moderately bullish on its future outlook.
Mizuho upgraded Palantir to “Outperform,” arguing the company is in a “category of one” thanks to its exceptional growth and margin expansion.
Netflix has trailed its sector peers recently, yet analysts remain moderately optimistic about the stock’s prospects.
Although AbbVie has lagged behind the Dow recently, analysts remain moderately optimistic about the stock’s prospects.
Accenture blends a 3% dividend with solid cash flow and significant growth potential.
Chevron has notably outpaced the Nasdaq recently, and analysts remain moderately optimistic about the stock’s prospects.
Snowflake shares have crashed significantly in recent months, but could the firm’s upcoming Q4 earnings release reverse SNOW stock’s trajectory? Let’s find out.
Advanced Micro Devices has outperformed the S&P 500 over the past year, and analysts remain cautiously optimistic about the stock’s growth potential.
UnitedHealth has underperformed the Dow over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Costco Wholesale has underperformed the S&P 500 over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Alphabet stock has outpaced the Nasdaq over the past year, and analysts remain highly bullish about its prospects.
Nvidia and OpenAI have abandoned talks for a $100 billion investment and are now finalizing a smaller, $30 billion deal.
Procter & Gamble has underperformed the Consumer Staples industry over the past year, but analysts are cautiously optimistic about the stock’s prospects.